Investigating Drug Interactions And Antibacterial Activity Of Vitamin C On Pathogenic Factors Of Escherichia Coli Clinical Isolates
Downloads
Today, the phenomenon of multi-drug resistance has become a major cause of concern, and insufficient achievements have been made in the development of new antibiotics for the treatment of bacterial infections. Therefore, there is an unmet need for new auxiliary search. Vitamin C is one such promising supplement. The current study was conducted with the aim of explaining the antibacterial interaction effect of vitamin C in different concentrations (5-20 mg/ml) and drugs effective on Escherichia coli bacteria. In order to collect clinical samples during the months of September to November 2022, clinical samples were collected from 100 patients suspected of urinary tract infection who referred to medical centers. For identification, biochemical tests and gram staining and culture in IMViC and EMB environments were used to see metallic green polish. Then antimicrobial sensitivity test And the effect of antibiotic on biofilm formation, the effect of antibiotic and ascorbic acid on biofilm formation, biofilm inhibition rate was done for the single and combined effects of both antimicrobial substances. Finally, in order to investigate and identify the virulence gene of the isolated strains, DNA extraction was performed by PCR method. 45 samples of urinary infection culture were identified from the total of 100 samples collected, in 45 (45%) of them colonies with metallic polish were observed. 45% were men and 55% were women, and of these, a total of 45 positive E. coli cases were found in women and 17 positive cases were seen in men. Less than one year, teenagers, young and old were divided. 2 cases (2%) were in the age group of less than one year, 3 cases (3%) were teenagers, 63 cases (63%) were young and 32 cases (32%) were in the age group of middle-aged people. In a situation where the ability to form biofilm under vitamin C (ascorbic acid) treatment was not very effective and did not differ much from normal conditions, antibiotic treatment (under MBC gentamicin treatment) was somewhat successful in inhibiting biofilm formation, finally with the combination of antibiotic and Ascorbic acid was completely isolated in many resistant strains, the inability to form biofilm was evident, and this indicated the synergistic effects in the investigated composition. As the results showed, the ability to produce biofilm in the samples that had the target genes in this study was not much different from the other samples. Considering the increasing resistance to some antibiotics and wide changes in the effective spectrum of drugs and preventing the increase of drug-resistant cases, the necessity of conducting drug sensitivity tests seems very necessary. The high prevalence of E. coli antibiotic resistance and the high percentage of resistance genes in patients suffering from infections caused by this bacterium can indicate the excessive use of antibiotics. Finally, the prevalence of antibiotic resistance is a useful marker for investigating resistance genes and can be useful in ecological investigations. Also, with clear inhibitory effects, the selected antibiotic in this study along with ascorbic acid, this vitamin can be used as a supplement in some infections caused by E. coli bacteria.
(1) Bensman, A., Dunand, O., & Ulinski, T. (2009). Urinary tract infections. In Pediatric Nephrology (pp. 1297-1310). Springer.
(2) Bien, J., Sokolova, O., & Bozko, P. (2012). Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. International journal of nephrology, 2012.
(3) Alexander C, Rietschel ET. (2001)Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res; 7 (3):167-202.
(4) Alhaji Brima Gogra, Jun Yao, Edward H.sandy.( 2010) cell surface hydrophobicity ( CSH) of Escherichia coli , Staphilococcus aureus and Aspergillus niger and the biodegradation of Diethyl phthalate (DEP) via microcalorimetry. J American Sci. 6(7) 78_88
(5) Allison C, Emody L, Coleman N et al. ( 1994)The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis.J Infect Dis; 169 (5):1155-8 .
(6) Bock, K., M. E. Breimer, A. Brignole, G. C. Hansson, K. A. Karlsson, G. Larson, H. Leffler, B. E. Samuelsson, N. Stromberg, C. S. Eden, and et al. (1985) Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1-4Gal-containing glycosphingolipids. J Biol Chem 260:8545-51.
(7) Bouguenec LC, Archambaud M, Labigne A.(1992) Rapid and specific detection of pap, afa ,and sfa adhesion encoding operons in uropathogenic E.coli strains by polymerase chain reaction. J Clin Microbiol;
(8) Bower J,Eto , Mulvey A.( 2005) Covert Operations of Uropathogenic Escherichia coli within the Urinary Tract. Blackwell Munksgaard. Traffic; 6: 18–31.
(9) Tahmourespour A, Kasra Kermanshahi R,Salehi R, Nabinejad A. (2008) The relationship between cell Surface hydrophobicity and antibiotic resistance of streptococcal strains isolated from dental plaque and caries. IJBMS. . Vol. 10, No. 4, Winter 2008, 251- 255
(10) F, S., & Strockbine, N. A. (2015). Escherichia. In Bergey's Manual of Systematics of Archaea and Bacteria. https://doi.org/doi:10.1002/9781118960608.gbm01147
(11) Meza-Segura, M., & Estrada-Garcia, T. (2016). Diffusely adherent Escherichia coli. In Escherichia coli in the Americas (pp. 125-147). Springer.
(12) Ochoa, T. J., & Contreras, C. A. (2011). Enteropathogenic escherichia coli infection in children. Curr Opin Infect Dis, 24(5), 478-483. https://doi.org/10.1097/QCO.0b013e32834a8b8b
(13) Rijavec, M., Erjavec, M. S., Avguštin, J. A., Reissbrodt, R., Fruth, A., Križan-Hergouth, V., & Žgur-Bertok, D. (2006). High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Current microbiology, 53(2), 158-162.
(14) Sik Kim, K. (2006). Meningitis-Associated Escherichia coli. EcoSal Plus, 2(1). https://doi.org/10.1128/ecosalplus.8.6.1.2
(15) Tadesse, D. A., Zhao, S., Tong, E., Ayers, S., Singh, A., Bartholomew, M. J., & McDermott, P. F. (2012). Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950–2002. Emerging infectious diseases, 18(5), 741.
(16) van den Beld, M., & Reubsaet, F. (2012). Differentiation between Shigella, enteroinvasive Escherichia coli (EIEC) and noninvasive Escherichia coli. European journal of clinical microbiology & infectious diseases, 31(6), 899-904.
(17) Vila, J., Sáez-López, E., Johnson, J., Römling, U., Dobrindt, U., Cantón, R., Giske, C., Naas, T., Carattoli, A., & Martínez-Medina, M. (2016). Escherichia coli: an old friend with new tidings. FEMS microbiology reviews, 40(4), 437-463
(18) WHO. (2020). Antimicrobial Resistance Global Report on Surveillance http://www.who.int/drugresistance/documents/surveillancereport/en/
Copyright (c) 2024 Osamah A Tuqi, Aya Aziz Hussein, Tabark abdukarim Hussein, REYADH R AL-RASHIDI, Mustafa Khudair Abbas

This work is licensed under a Creative Commons Attribution 4.0 International License.














